Infliximab for the treatment of rheumatoid arthritis.

BACKGROUND: Infliximab is a human murine chimeric anti-tumour necrosis factor alpha monoclonal antibody recently approved for the treatment of refractory RA. OBJECTIVES: To assess the efficacy and safety of infliximab for the treatment of rheumatoid arthritis. SEARCH STRATEGY: Electronic databases...

詳細記述

書誌詳細
主要な著者: Blumenauer, B, Judd, M, Wells, G, Burls, A, Cranney, A, Hochberg, M, Tugwell, P
フォーマット: Journal article
言語:English
出版事項: 2002

類似資料